Top Research Reports for Amazon, Stryker & Lam Research

Zacks12-04

Tuesday, December 3, 2024 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Amazon.com,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2488530908?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/abvxxpw_EhiJ5CndgtV9gg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9507176d9255e9dd39381c57df9d94b3","is_english":true,"pubTime":"2024-12-04 05:27","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2488530908","market":"us","top_or_hot":-1,"title":"Top Research Reports for Amazon, Stryker & Lam Research","media":"Zacks","content":"<div>\n<p>Tuesday, December 3, 2024\nThe Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Amazon.com,...</p>\n\n<a href=\"https://finance.yahoo.com/news/top-research-reports-amazon-stryker-212700504.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Research Reports for Amazon, Stryker & Lam Research</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Research Reports for Amazon, Stryker & Lam Research\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-04 05:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/top-research-reports-amazon-stryker-212700504.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tuesday, December 3, 2024\nThe Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Amazon.com,...</p>\n\n<a href=\"https://finance.yahoo.com/news/top-research-reports-amazon-stryker-212700504.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0323591593.USD","symbol_name":"SCHRODER ISF QEP GLOBAL QUALITY \"A\" (USD) ACC","start_time":0,"source_url":"https://finance.yahoo.com/news/top-research-reports-amazon-stryker-212700504.html","article_id":"2488530908","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/abvxxpw_EhiJ5CndgtV9gg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9507176d9255e9dd39381c57df9d94b3"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2488530908","pubTimestamp":1733261220,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Amazon’s shares have outperformed the Zacks Internet – Commerceindustry over the past year . The Zacks analyst believes that strengthening AWS services portfolio and its growing adoption rate have contributed well to the stock's performance. Ultrafast delivery services, expanding content portfolio and Amazon’s expanding global presence have also benefited the company. Deepening focus on generative AI is a major plus.However, macroeconomic challenges remain headwinds. Rising transportation and fulfillment center costs are concerns.Stryker’s shares have outperformed the Zacks Medical - Products industry over the past year . The Zacks analyst believes that strong international sales, ongoing procedural recovery and a strong order book for capital equipment bode well for the company. Strong customer demand is a major plus.Yet, inflationary pressure and supply-chain challenges continue to plague Stryker. Stiff competition in the MedTech space remains a headwind.However, the company is ridin","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0323591593.USD":"SCHRODER ISF QEP GLOBAL QUALITY \"A\" (USD) ACC","LU0724617625.USD":"BGF GLOBAL ALLOCATION \"A4\" (USD) INC","ZION":"齐昂银行","LU0316494557.USD":"FRANKLIN GLOBAL FUNDAMENTAL STRATEGIES \"A\" ACC","SGXZ31699556.SGD":"UGDP UNITED GLOBAL QUALITY GROWTH \"C\" (SGDHDG) ACC","ICCC":"伊芙美尔医疗","LU0130103400.USD":"Natixis Harris Associates Global Equity RA USD","LU0820561818.USD":"安联收益及增长平衡基金Cl AM DIS","AXSM":"Axsome Therapeutics, Inc.","IE00B19Z8W00.USD":"FTGF CLEARBRIDGE US LARGE CAP GROWTH \"A\" INC","IE00B7KXQ091.USD":"Janus Henderson Balanced A Inc USD","LRCX":"拉姆研究","LU0256863811.USD":"ALLIANZ US EQUITY \"A\" INC","IE00B19Z8X17.USD":"FTGF CLEARBRIDGE US LARGE CAP GROWTH  \"AG\" (USD) ACC","IE00BJLML261.HKD":"HSBC GLOBAL EQUITY INDEX \"HCH\" (HKD) ACC","ARW":"艾睿","LU0107464264.USD":"abrdn SICAV I - GLOBAL INNOVATION EQUITY \"A\" (USD) ACC","LU0238689110.USD":"贝莱德环球动力股票基金","LU0889565833.HKD":"FRANKLIN TECHNOLOGY \"A\" (HKD) ACC","SIMO":"慧荣科技","DKS":"迪克体育用品","IE00B1XK9C88.USD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A\" (USD) ACC","LU0310800379.SGD":"FTIF - Templeton Global A Acc SGD","LU1084165304.USD":"FIDELITY WORLD \"A\" (USD) ACC","LU2023250504.SGD":"Allianz Thematica Cl AMg DIS H2-SGD","BK4524":"宅经济概念","DUK":"杜克能源","LU1880398554.USD":"AMUNDI FUNDS GLOBAL EQUITY \"A2\" (USD) INC","IE00BKDWB100.SGD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A5H\" (SGDHDG) ACC","BK4167":"医疗保健技术","LU0820562030.AUD":"ALLIANZ INCOME AND GROWTH \"AMH2\" (AUDHDG) H2 INC","BK4559":"巴菲特持仓","LU0109392836.USD":"富兰克林科技股A","CVNA":"Carvana Co.","AMZN":"亚马逊","IE0034235303.USD":"PINEBRIDGE US RESEARCH ENHANCED CORE EQUITY \"A\" (USD) ACC","HCA":"HCA控股","LU2264538146.SGD":"Fullerton Lux Funds - Global Absolute Alpha A Acc SGD","IE0004445015.USD":"JANUS HENDERSON BALANCED \"A2\" (USD) ACC","LU2384288077.EUR":"AZ EQUITY GLOBAL INFRASTRUCTURE \"A-INS\" (EUR) ACC","OMCL":"Omnicell","LU2456880835.USD":"ALLIANZ GLOBAL INCOME \"AT\" (USD) ACC","LU2552382058.USD":"WELLINGTON US BRAND POWER \"A\" (USD) ACC","LU0061474705.USD":"THREADNEEDLE (LUX) GLOBAL DYNAMIC REAL RETURN \"AU\" (USD) ACC","SYK":"史赛克","AON":"怡安保险","LU1430594728.SGD":"Eastspring Investments - Global Low Volatility Equity AS SGD","LU2326559502.SGD":"Natixis Loomis Sayles US Growth Equity P/A SGD-H","LNG":"Cheniere Energy Inc"},"translate_title":"亚马逊、Stryker和Lam Research的热门研究报告","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AON":1,"ZION":1,"SYK":1,"SIMO":1,"OMCL":1,"LRCX":1,"LNG":1,"ICCC":1,"HCA":1,"DKS":1,"AMZN":1,"ARW":1,"AXSM":1,"CVNA":1,"DUK":0.9},"content_text":"Tuesday, December 3, 2024\nThe Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Stryker Corp. (SYK) and Lam Research Corp. (LRCX), as well as a micro-cap stock, ImmuCell Corp. (ICCC). These research reports have been hand-picked from roughly 70 reports published by our analyst team today.You can see all of today’s research reports here >>>\nAmazon’s shares have outperformed the Zacks Internet – Commerce industry over the past year (+45.5% vs. +40.8%). The Zacks analyst believes that strengthening AWS services portfolio and its growing adoption rate have contributed well to the stock's performance. Ultrafast delivery services, expanding content portfolio and Amazon’s expanding global presence have also benefited the company. Deepening focus on generative AI is a major plus.\nHowever, macroeconomic challenges remain headwinds. Rising transportation and fulfillment center costs are concerns.\n(You can read the full research report on Amazon here >>>)\nStryker’s shares have outperformed the Zacks Medical - Products industry over the past year (+33.9% vs. +20.9%). The Zacks analyst believes that strong international sales, ongoing procedural recovery and a strong order book for capital equipment bode well for the company. Strong customer demand is a major plus.\nYet, inflationary pressure and supply-chain challenges continue to plague Stryker. Stiff competition in the MedTech space remains a headwind.\n(You can read the full research report on Stryker here >>>)\nShares of Lam Research have underperformed the Zacks  Electronics – Semiconductors industry over the past year (+10.6% vs. +45.7%). Per the Zacks analyst, global spending on mature nodes is likely to be flat year over year. Growing tensions between the United States and China remain major concerns and have contributed to the stocks underperformance this year.\nHowever, the company is riding on its strength across 3D DRAM and advanced packaging technologies. Also, rebound in the system business owing to improving memory spending is a positive.\n(You can read the full research report on Lam Research here >>>)\nImmucell’s shares have underperformed the Zacks Medical - Products industry over the last six months (-3.9% vs. +11.9%). The Zacks analyst believes that the company has been hindered by high production costs and increased depreciation from expanded facilities. High customer concentration, shareholder dilution and competition from giants like Zoetis and Merck also pose risks.\nYet, robust customer demand for First Defense has been a key driver of sales growth. The remediation of contamination issues and investments in capacity expansion have positioned the company to stabilize output at higher levels.\n(You can read the full research report on Immucell here >>>)\nOther noteworthy reports we are featuring today include Duke Energy Corp. (DUK), Aon plc (AON) and HCA Healthcare, Inc. (HCA).Mark VickerySenior EditorNote: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>\nToday's Must Read\nPrime Momentum & Growing AWS Adoption Benefit Amazon (AMZN)\nLam Research (LRCX) Benefits From Etch & Deposition Strength\nDiversified Product Portfolio Drives Stryker's (SYK) Prospects\nFeatured Reports\nAxsome's (AXSM) Marketed Drugs Drive Growth Amid CompetitionPer the Zacks analyst, Axsome's lead drug, Auvelity, approved for treating major depressive disorder is driving sales. The addition of Sunosi bodes well too. However, stiff competition remains a woe.\nInvestments Aid Duke Energy (DUK), Poor Financials May HurtPer the Zacks analyst, solid investments in infrastructure and expansion projects boost Duke Energy's growth. Yet the company's poor financial position might remain a concern for its investors.\nCheniere Energy's (LNG) Gas Export Dominance Bodes WellThe Zacks analyst likes Cheniere's competitive advantage of being the first and dominant natural gas exporter in the U.S. market but is concerned over the huge debt load of nearly $22.5 billion.\nBroadridge Gains From Itiviti Buyout, Amid High CompetitionPer the Zacks analyst, the Itiviti acquisition has boosted Broadridge's global technology and operations segment. High competition from other players is an overhang.\nAon's (AON) Strategic Acquisitions Aid, Debt Woes LingerPer the Zacks analyst, several acquisitions and collaborations are helping AON enhance its capabilities, driving its profit growth. However, rising debts remain a concern.\nImproving Top Line, Acquisitions Aid HCA Healthcare (HCA)Per the Zacks analyst, its growing revenues driven by increasing admissions have led to significant growth. Strategic acquisitions have helped it expand and remains a driving factor.\nDICK'S Sporting (DKS) Brand Strength & Store Expansion GoodDICK'S Sporting Goods has been benefiting from brand strength and continued market share gains. In addition, the company's store-expansion initiatives bode well.\nNew Upgrades\nDecent Loan Demand, High Fee Income, Rates Aid Zions (ZION)Per the Zacks analyst, modest loan demand, improving fee income and relatively high rates will likely aid Zions' financials. Given a solid balance sheet, its capital distributions are sustainable.\nStrong Uptake of XT Amplify Program Aids Omnicell (OMCL)The Zacks analyst is impressed with the strong uptake of Omnicell's XT Amplify program which is helping it to gain good momentum in automation and analytics business.\nCarvana's (CVNA) Cost-Containment Initiatives Paying OffCarvana's focus on reducing reconditioning and transportation costs and boosting operational efficiency is driving margin growth and supporting the Zacks analyst's bullish stance.\nNew Downgrades\nMacroeconomic Woes Hurt Silicon Motion's (SIMO) ProfitabilityPer the Zacks Analyst, macroeconomic headwinds and geopolitical instability are hurting Silicon Motion's (SIMO) profitability. Integration risks owing to frequent buyouts are concerning.\nCyclical headwinds, Unfavorable Forex Hurts Arrow Electronics (ARW)Per the Zacks Analyst, cyclical headwinds and unfavorable foreign currency exchange rates are expected to hurt ARW's top-line growth in the near term.\nLeggett Ails From Weak Demand in Residential End MarketsPer the Zacks analyst, Leggett witnessed weak demand in residential end markets due to a challenging macro environment and soft consumer spending.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report\nAmazon.com, Inc. (AMZN) : Free Stock Analysis Report\nDuke Energy Corporation (DUK) : Free Stock Analysis Report\nStryker Corporation (SYK) : Free Stock Analysis Report\nLam Research Corporation (LRCX) : Free Stock Analysis Report\nAon plc (AON) : Free Stock Analysis Report\nHCA Healthcare, Inc. (HCA) : Free Stock Analysis Report\nTo read this article on Zacks.com click here.\nZacks Investment Research","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2488530908"}